Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

DenmarkBack to Denmark

Clinical trials in Nykøbing Falster

4 clinical trials in Nykøbing Falster, Denmark. Every trial is listed in the EU Clinical Trials Register and updated daily.

DenmarkOur site in DenmarkKliniske-Forsoeg.dk(opens in a new tab)
Nykøbing Falster at a glance
4
clinical trials
  • Not yet recruiting0
  • Research sites0
Type of trial
Recruitment status
Quick filters

4 trials in Nykøbing Falster

Open in trial search

Sepsis+1

Recruiting
Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Linezolid
  • Sponsor:Region Hovedstaden

Type 1 diabetes mellitus

Recruiting
Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Finerenone
  • Sponsor:Steno Diabetes Center Copenhagen

Type 2 diabetes mellitus

Not recruiting
Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Atenolol
  • Sponsor:Odense University Hospital

Other cities in Denmark

The busiest research cities in the country

All 47 cities in Denmark

Clinical research in Nykøbing Falster

What the registry says about research in the country

01 Nykøbing Falster
Cardiovascular Disease and Type 1 Diabetes
Research in type 1 diabetes is concentrating on combined metabolic and cardiac strategies to lower the incidence of cardiovascular disease and associated complications. Intensified care protocols guided by metabolic fitness indices Evaluation of finerenone for heart‑failure risk reduction Integrated endocrine‑cardiac risk assessment models Focused endpoints on mortality and hospital admissions Both recruiting studies are based in Nykøbing Falster, showcasing active investigator participation even with limited trial sites.
Bacterial Infections and Sepsis
Ongoing work targets severe sepsis and septic shock, comparing first‑line antimicrobial regimens to improve survival and patient‑centred outcomes. Empirical comparison of meropenem versus piperacillin/tazobactam Assessment of mortality and organ‑failure metrics Optimization of critical‑care antibiotic pathways Contribution to antimicrobial stewardship practices The trials are actively recruiting in Nykøbing Falster, reflecting local commitment to advancing treatment for life‑threatening infections.
Back to DenmarkAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.